Legend Biotech (LEGN) Non-Current Deferred Tax Liability (2019 - 2021)

Legend Biotech's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $22.8 million for Q4 2021.

• Quarterly Non-Current Deferred Tax Liability rose 436.69% year-over-year to $22.8 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $22.8 million (up 436.69% YoY) and the FY2021 annual result came in at $22.8 million, up 436.69% from the prior year.
• Non-Current Deferred Tax Liability was $22.8 million for Q4 2021 at Legend Biotech, up from $4.2 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $47.7 million in Q4 2019 and bottomed at $4.2 million in Q4 2020.
• A 3-year average of $24.9 million and a median of $22.8 million in 2021 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2020 — Non-Current Deferred Tax Liability plunged 91.11% — and 2021, when it surged 436.69%.
• Legend Biotech's Non-Current Deferred Tax Liability stood at $47.7 million in 2019, then plunged by 91.11% to $4.2 million in 2020, then jumped by 436.69% to $22.8 million in 2021.
• Business Quant data shows LEGN's Non-Current Deferred Tax Liability at $22.8 million in Q4 2021, $4.2 million in Q4 2020, and $47.7 million in Q4 2019.